News & Updates

Show Multimedia Only

Prilocaine/lidocaine spray safe, effective in men with premature ejaculation

05 May 2022

The eutectic-like mixture of prilocaine/lidocaine spray appears to work well in the treatment of men with various types of premature ejaculation, as reflected by a high treatment adherence, according to data from a real-world study.

05 May 2022

Adult-sized instruments feasible for use in paediatric percutaneous nephrolithotomy

04 May 2022

Performing percutaneous nephrolithotomy (PCNL) with adult-sized instruments in children yields comparable outcomes as when using paediatric-sized instruments, according to a study.

04 May 2022

Long-term efficacy of Aquablation for BPH not dictated by prostate volume

01 May 2022

Aquablation therapy appears to be effective in benign prostatic hyperplasia (BPH) patients experiencing lower urinary tract symptoms, with the favourable effects sustained over a 3-year follow-up while having few irreversible complications and low retreatment rates across all prostate volumes, according to a study.

01 May 2022

Noninfectious complications common after transrectal prostate needle biopsy

30 Apr 2022

Compared with infections, noninfectious complications are more than twice as common following transrectal prostate needle biopsy (TRUS PNB), reports a recent study.

30 Apr 2022

Intensified systemic therapy with ADT improves outcomes in high-risk prostate cancer

27 Apr 2022

In patients with high-risk or unfavourable nonmetastatic prostate cancer (nmPC) receiving local definite therapy, the intensification of systemic therapy using chemotherapy or an androgen receptor signaling inhibitor (ARSI), in combination with androgen deprivation therapy (ADT), leads to better oncologic survival measures, reports a recent meta-analysis.

27 Apr 2022

Larger tumours tied to prostate cancer biochemical recurrence

22 Apr 2022

In patients with localized prostate cancer (PCa), higher tumour volume (TV) appears to cut biochemical recurrence-free survival short, a recent study has found.

22 Apr 2022

Androgen deprivation therapy for prostate cancer ups dementia risk

18 Apr 2022 by

Adult men with prostate cancer who have increasing exposure to androgen deprivation therapy (ADT) are at greater risk of dementia, according to a US study.

18 Apr 2022

High-intensity training eases anxiety, stress in prostate cancer

17 Apr 2022

A supervised high-intensity interval training (HIIT) program for 12 weeks leads to improvements in prostate cancer-specific anxiety, fear of cancer progression, hormone symptoms, stress, fatigue, and self-esteem in men on active surveillance, reports a study.

17 Apr 2022

Tamsulosin–mirabegron combo improves urination frequency but not voiding volume

14 Apr 2022

Treatment with the combination of tamsulosin plus mirabegron following 125I-brachytherapy for prostate cancer falls short of improving voiding volume compared with tamsulosin monotherapy, although the combination helps with urination frequency and overactive bladder symptoms, according to a study.

14 Apr 2022

Motion-based digital device allows effective self-management of urinary incontinence

13 Apr 2022 by

Use of a motion-based digital device to guide pelvic floor muscle training effectively mitigates symptoms of urinary incontinence (UI) as well as reduces UI episodes relative to a home training program that consists of written and narrated instructions, as shown in a study.

13 Apr 2022